( OUR VISION ) The future delivered by our research
Cancer, though a common disease, remains one of the most feared. Our laboratory is developing nanoparticles capable of freely controlling the immune response to cancer, and elucidating the immune response to cancer, thereby creating a new drug discovery platform for cancer immunotherapy. For a future where cancer becomes a truly common disease.